In Breast Cancer Research : BCR, 2001
... Rat anti-mouse CD45-PE-Cy5 and CD45-PE-Cy7 (clone 30-F11; used at 0.25 μg/ml) and anti-CD24-FITC (clone M1/69; used at 0.5 μg/mL) were obtained from BD Biosciences (Oxford, UK) ...
New Findings on Breast Cancer Stem Cells: A Review.
Kermānshāh, Iran. In J Breast Cancer, Dec 2015
It appears that this small subpopulation of cells, with the capacity for self-renewal and a high proliferation rate, originate from normal stem cells, are identified by specific markers such as CD44(+)/CD24(-/low), and enhance a tumor's capacity for metastasis, invasion, and therapy resistance.
Cancer stem cells in human digestive tract malignancies.
Mashhad, Iran. In Tumour Biol, Nov 2015
For instance, identification of markers associated with digestive tract CSCs, such as CD44, CD133, CD24, EpCAM, LGR5, ALDH1, and BMI1, has made it possible to develop more accurate diagnosis approaches.
Dendritic cells decide CD8(+) T cell fate.
Glasgow, United Kingdom. In Immunity, 2014
(2014) propose that CD103(+) DCs in mouse lung selectively generate effector CD8(+) T cells by binding the alarmin HMGB1 via CD24 and presenting it to RAGE(+) T cells.